Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort study
I feel better now than I did at 27. 4
Clinical indicators for tirzepatide include more severe metabolic dysfunction, higher baseline HbA1c, or prior inadequate response to semaglutide monotherapy
As such, Medicare has announced that members of its Part D plan can access the medication through their plan, as long as it is prescribed specifically to reduce the risk of heart attacks and strokes
Thyroid disorders, including Hashimotos thyroiditis and hypothyroidism, are common in people with metabolic diseases like diabetes and obesity
Hair loss concerns are less documented with retatrutide than with some other GLP-1 agonists, but the rapid weight loss itself can trigger telogen effluvium, a temporary shedding condition